Sodium/glucose cotransporter 2: Difference between revisions
Created page with "{{Short description|Protein-coding gene in the species Homo sapiens}} {{Infobox gene}} The '''sodium/glucose cotransporter 2''' (SGLT2) is a protein that in humans is encoded by the {{gene|SLC5A2}} (solute carrier family 5 (sodium/glucose cotransporter)) gene. == Function == SGLT2 is a member of the sodium glucose cotransporter family, which are sodium-dependent glucose transport proteins. SGLT2 is the major cotransport..." |
Marked this version for translation |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
<languages /> | |||
<translate> | |||
<!--T:1--> | |||
{{Short description|Protein-coding gene in the species Homo sapiens}} | {{Short description|Protein-coding gene in the species Homo sapiens}} | ||
{{Infobox gene}} | {{Infobox gene}} | ||
<!--T:2--> | |||
The '''sodium/glucose cotransporter 2''' (SGLT2) is a [[protein]] that in humans is encoded by the {{gene|SLC5A2}} (solute carrier family 5 (sodium/glucose cotransporter)) [[gene]]. | The '''sodium/glucose cotransporter 2''' (SGLT2) is a [[protein]] that in humans is encoded by the {{gene|SLC5A2}} (solute carrier family 5 (sodium/glucose cotransporter)) [[gene]]. | ||
== Function == | == Function == <!--T:3--> | ||
SGLT2 is a member of the [[sodium-glucose transport proteins|sodium glucose cotransporter family]], which are sodium-dependent [[glucose]] transport proteins. SGLT2 is the major cotransporter involved in glucose [[reabsorption]] in the kidney. SGLT2 is located in the early [[proximal tubule]], and is responsible for reabsorption of 80-90% of the glucose filtered by the kidney [[Glomerulus (kidney)|glomerulus]]. Most of the remaining glucose absorption is by [[sodium/glucose cotransporter 1]] (SGLT1) in more distal sections of the proximal tubule. | SGLT2 is a member of the [[sodium-glucose transport proteins|sodium glucose cotransporter family]], which are sodium-dependent [[glucose]] transport proteins. SGLT2 is the major cotransporter involved in glucose [[reabsorption]] in the kidney. SGLT2 is located in the early [[proximal tubule]], and is responsible for reabsorption of 80-90% of the glucose filtered by the kidney [[Glomerulus (kidney)|glomerulus]]. Most of the remaining glucose absorption is by [[sodium/glucose cotransporter 1]] (SGLT1) in more distal sections of the proximal tubule. | ||
== SGLT2 inhibitors for diabetes == | == SGLT2 inhibitors for diabetes == <!--T:4--> | ||
{{Main|SGLT2 inhibitor}} | {{Main|SGLT2 inhibitor}} | ||
[[SGLT2 inhibitor]]s are also called gliflozins or flozins. They lead to a reduction in blood glucose levels, and therefore have potential use in the treatment of [[type 2 diabetes]]. Gliflozins enhance glycemic control as well as reduce [[Human body weight|body weight]] and systolic and diastolic [[blood pressure]]. The gliflozins canagliflozin, dapagliflozin, and empagliflozin may lead to euglycemic [[ketoacidosis]]. Other side effects of gliflozins include increased risk of Fournier gangrene | [[SGLT2 inhibitor]]s are also called gliflozins or flozins. They lead to a reduction in blood glucose levels, and therefore have potential use in the treatment of [[type 2 diabetes]]. Gliflozins enhance glycemic control as well as reduce [[Human body weight|body weight]] and systolic and diastolic [[blood pressure]]. The gliflozins canagliflozin, dapagliflozin, and empagliflozin may lead to euglycemic [[ketoacidosis]]. Other side effects of gliflozins include increased risk of Fournier gangrene | ||
== Clinical significance == | == Clinical significance == <!--T:5--> | ||
<!--T:6--> | |||
Mutations in this gene are also associated with [[renal glycosuria]]. | Mutations in this gene are also associated with [[renal glycosuria]]. | ||
== See also == | == See also == <!--T:7--> | ||
* [[SGLT]] Family | * [[SGLT]] Family | ||
* [[Discovery and development of gliflozins]] | * [[Discovery and development of gliflozins]] | ||
* [[Phlorizin]] — a competitive inhibitor of [[SLC5A1|SGLT1]] and [[SGLT2]] | * [[Phlorizin]] — a competitive inhibitor of [[SLC5A1|SGLT1]] and [[SGLT2]] | ||
== References == | == References == <!--T:8--> | ||
{{reflist|33em}} | {{reflist|33em}} | ||
== Further reading == | == Further reading == <!--T:9--> | ||
{{refbegin|33em}} | {{refbegin|33em}} | ||
* {{cite journal | vauthors = van den Heuvel LP, Assink K, Willemsen M, Monnens L | title = Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2) | journal = Human Genetics | volume = 111 | issue = 6 | pages = 544–7 | date = Dec 2002 | pmid = 12436245 | doi = 10.1007/s00439-002-0820-5 | s2cid = 28089635 }} | * {{cite journal | vauthors = van den Heuvel LP, Assink K, Willemsen M, Monnens L | title = Autosomal recessive renal glucosuria attributable to a mutation in the sodium glucose cotransporter (SGLT2) | journal = Human Genetics | volume = 111 | issue = 6 | pages = 544–7 | date = Dec 2002 | pmid = 12436245 | doi = 10.1007/s00439-002-0820-5 | s2cid = 28089635 }} | ||
Line 34: | Line 39: | ||
{{refend}} | {{refend}} | ||
<!--T:10--> | |||
{{Solute carrier family|bg|bg0}} | {{Solute carrier family|bg|bg0}} | ||
{{Sodium-glucose transporter modulators}} | {{Sodium-glucose transporter modulators}} | ||
{{二次利用|date=18 December 2023}} | {{二次利用|date=18 December 2023}} | ||
<!--T:11--> | |||
[[Category:Solute carrier family]] | [[Category:Solute carrier family]] | ||
[[Category:Genes mutated in mice]] | [[Category:Genes mutated in mice]] | ||
</translate> |